Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000274964, named "novel transcript, sense intronic to BICD1," is annotated as an RNA gene located within an intron of the BICD1 gene and transcribed in the same sense direction[1]. There are no known protein products, molecular functions, or roles as a receptor, enzyme, transporter, or other classical therapeutic target associated with it. It is not classified as a target in drug discovery, nor does it have known associations with disease, drugs, or biomarker status[1]. The available information indicates an incomplete and uncharacterized gene, which may represent a non-coding RNA of uncertain significance. This entry is likely not a correct drug discovery target, nor has it been robustly studied in most biomedical databases[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to BICD1.